Article
Loss of miR-16-1-3p Activity Predicts Chemoresistance and Progression in Osteosarcoma: An Integrative Clinicopathologic Study
2025-11-13
Abstract excerpt
<title>Abstract</title> <p>Introduction Chemotherapy resistance contributes significantly to mortality in osteosarcoma (OS) patients. The role of miR-16, miR-16-1-3p, and miR-16-2-3p in modulating chemotherapy response and disease progression in OS remains unclear. Methods RNA-seq and clinical data from 82 OS patients in the TARGET-OS database were analyzed. Patients were classified by progression status (progres...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a2cd8c12-6c65-5a2b-a3fe-6b4b822d60b4
- DOI
- 10.21203/rs.3.rs-7665473/v1
